VR Logo

Biofil Chemicals & Pharmaceuticals Ltd.


Healthcare | Drugs & Pharma

we think vacations are for wimps

38 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Manufacture of allopathic pharmaceutical preparations

Incorporated: 1985

Chairman: --

Managing Director: Ramesh Shah

Group: --

Listing: NSE: BIOFILCHEM, BSE: 524396

Headquarters: Indore, Madhya Pradesh

Website: www.biofilgroup.com/www.biofilgroup.net

Key Facts

Market cap: R 22.49 Cr

Revenue (TTM): R 28.45 Cr

Earnings (TTM): R 1.15 Cr

Cash: R 0.14 Cr

Total Debt: R 1.64 Cr

Promoters' ownership: 46.82%

Liquidity: Moderate

52 Week range: R 4.05 - 22.70

Face value: R10.00

Shares outstanding: 1,62,73,800

10 Years Aggregate:

  • CFO: 3.98 Cr
  • EBITDA: 6.70 Cr
  • Net Profit: 6.86 Cr

Stock Performance

Time Period Biofil Chemicals & Pharma S&P BSE Healthcare S&P BSE Small Cap
YTD-18.9915.56-23.18
1 month16.922.59-1.10
3 months25.876.76-28.63
1 Year81.9116.76-26.76
3 Years6.282.02-11.24
5 Years29.05-1.90-1.25
10 Years15.1411.372.26
As on 22-May-2020
Year Biofil Chemicals & Pharma S&P BSE Small Cap S&P BSE Healthcare
2019156.54-6.85-3.55
2018-60.10-23.41-5.89
2017105.0259.640.49
2016-2.741.77-12.88
2015337.166.7615.06
2014-0.5469.2447.43
2013-34.33-11.2322.55